| Mar 5, 2026 |
Mar 6, 2026 |
Herman Jenny
|
CAO |
Sell |
40.6
|
-1,383
|
-3.82%
|
✓
|
$17.8K |
| Mar 5, 2026 |
Mar 6, 2026 |
Jain Rachit
|
CFO |
Sell |
40.6
|
-1,631
|
-3.01%
|
✓
|
$21K |
| Mar 5, 2026 |
Mar 6, 2026 |
Tran Yvonne
|
EVP, CLO & CPO |
Sell |
44.4
|
-1,094
|
-2.03%
|
✓
|
$14.1K |
| Mar 5, 2026 |
Mar 6, 2026 |
Farid Ramy
|
CEO |
Sell |
48.1
|
-3,661
|
-1.09%
|
✓
|
$47.2K |
| Mar 5, 2026 |
Mar 6, 2026 |
Akinsanya Karen
|
Officer |
Sell |
48.1
|
-1,366
|
-1.92%
|
✓
|
$17.6K |
| Mar 5, 2026 |
Mar 6, 2026 |
Lorton Kenneth Patrick
|
COO |
Sell |
48.1
|
-1,222
|
-1.35%
|
✓
|
$15.8K |
| Mar 4, 2026 |
Mar 6, 2026 |
Abel Robert Lorne
|
Officer |
Sell |
44.4
|
-1,300
|
-2.27%
|
✓
|
$16.7K |
| Mar 2, 2026 |
Mar 3, 2026 |
Friesner Richard
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 2, 2026 |
Mar 3, 2026 |
Farid Ramy
|
CEO |
Sell |
95.0
|
+112,553
|
50.72%
|
✓
|
$66.2K |
| Mar 2, 2026 |
Mar 3, 2026 |
Jain Rachit
|
CFO |
Neutral |
90.0
|
+17,130
|
46.18%
|
✗
|
- |
| Mar 2, 2026 |
Mar 3, 2026 |
Tran Yvonne
|
EVP, CLO & CPO |
Neutral |
90.0
|
+30,918
|
135.26%
|
✗
|
- |
| Mar 2, 2026 |
Mar 3, 2026 |
Lorton Kenneth Patrick
|
COO |
Neutral |
90.0
|
+37,812
|
71.82%
|
✗
|
- |
| Mar 2, 2026 |
Mar 3, 2026 |
Herman Jenny
|
CAO |
Neutral |
90.0
|
+9,590
|
36.06%
|
✗
|
- |
| Mar 2, 2026 |
Mar 3, 2026 |
Akinsanya Karen
|
Officer |
Sell |
91.3
|
+55,697
|
356.46%
|
✓
|
$26.5K |
| Mar 2, 2026 |
Mar 3, 2026 |
Aklian Mannix Vartan
|
Officer |
Neutral |
90.0
|
+17,130
|
121.81%
|
✗
|
- |
| Mar 2, 2026 |
Mar 3, 2026 |
Abel Robert Lorne
|
Officer |
Neutral |
90.0
|
+37,812
|
195.06%
|
✗
|
- |
| Feb 10, 2026 |
Feb 12, 2026 |
Tran Yvonne
|
EVP, CLO & CPO |
Sell |
40.6
|
-776
|
-3.28%
|
✓
|
$10.7K |
| Feb 10, 2026 |
Feb 12, 2026 |
Lorton Kenneth Patrick
|
COO |
Sell |
48.1
|
-925
|
-1.73%
|
✓
|
$12.7K |
| Feb 10, 2026 |
Feb 12, 2026 |
Herman Jenny
|
CAO |
Sell |
44.4
|
-752
|
-2.75%
|
✓
|
$10.4K |
| Feb 9, 2026 |
Feb 11, 2026 |
Abel Robert Lorne
|
Officer |
Sell |
35.6
|
-1,230
|
-5.97%
|
✓
|
$16.6K |
| Oct 16, 2025 |
Oct 17, 2025 |
Dugan Margaret
|
Chief Medical Officer |
Sell |
36.3
|
-1,395
|
-5.37%
|
✓
|
$29.4K |
| Jun 18, 2025 |
Jun 20, 2025 |
Chodakewitz Jeffrey
|
Director |
Neutral |
90.0
|
+5,997
|
53.31%
|
✗
|
- |
| Jun 18, 2025 |
Jun 20, 2025 |
Sender Gary
|
Director |
Neutral |
90.0
|
+5,997
|
53.31%
|
✗
|
- |
| Jun 18, 2025 |
Jun 20, 2025 |
Lynton Michael
|
Director |
Neutral |
90.0
|
+5,997
|
53.31%
|
✗
|
- |
| Jun 18, 2025 |
Jun 20, 2025 |
van Kralingen Bridget A
|
Director |
Neutral |
90.0
|
+1,499
|
14.99%
|
✗
|
- |
| Jun 18, 2025 |
Jun 20, 2025 |
Thornberry Nancy
|
Director |
Neutral |
90.0
|
+5,997
|
53.31%
|
✗
|
- |
| Jun 18, 2025 |
Jun 20, 2025 |
Kapeller-Libermann Rosana
|
Director |
Neutral |
90.0
|
+5,997
|
53.31%
|
✗
|
- |
| Jun 18, 2025 |
Jun 20, 2025 |
GINSBERG GARY L
|
Director |
Neutral |
90.0
|
+5,997
|
53.31%
|
✗
|
- |
| Jun 18, 2025 |
Jun 20, 2025 |
OBEROI ARUN
|
Director |
Neutral |
90.0
|
+5,997
|
53.31%
|
✗
|
- |
| Jun 18, 2025 |
Jun 20, 2025 |
Friesner Richard
|
Director |
Neutral |
60.0
|
+5,997
|
0.48%
|
✗
|
- |
| May 29, 2025 |
May 29, 2025 |
Aklian Mannix Vartan
|
Officer |
Neutral |
90.0
|
+14,063
|
100.00%
|
✗
|
- |
|
May 29, 2025 |
Aklian Mannix Vartan
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 21, 2025 |
May 22, 2025 |
Jain Rachit
|
CFO |
Neutral |
90.0
|
+9,375
|
33.82%
|
✗
|
- |
|
May 22, 2025 |
Jain Rachit
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 15, 2025 |
Akinsanya Karen
|
President |
Sell |
7.5
|
-16,723
|
-51.70%
|
✓
|
$419.6K |
| Mar 7, 2025 |
Mar 10, 2025 |
van Kralingen Bridget A
|
Director |
Neutral |
90.0
|
+10,000
|
100.00%
|
✗
|
- |
|
Mar 10, 2025 |
van Kralingen Bridget A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 6, 2025 |
Mar 7, 2025 |
Herman Jenny
|
SVP & Controller |
Sell |
45.0
|
-666
|
-2.38%
|
✓
|
$14.1K |
| Mar 3, 2025 |
Mar 4, 2025 |
Porges Geoffrey Craig
|
CFO |
Sell |
95.0
|
+21,859
|
384.50%
|
✓
|
$119.5K |
| Mar 3, 2025 |
Mar 4, 2025 |
Akinsanya Karen
|
President |
Neutral |
90.0
|
+15,625
|
100.00%
|
✗
|
- |
| Mar 3, 2025 |
Mar 4, 2025 |
Farid Ramy
|
CEO |
Neutral |
90.0
|
+37,500
|
20.33%
|
✗
|
- |
| Mar 3, 2025 |
Mar 4, 2025 |
Dugan Margaret
|
Chief Medical Officer |
Neutral |
90.0
|
+12,500
|
92.81%
|
✗
|
- |
| Mar 3, 2025 |
Mar 4, 2025 |
Herman Jenny
|
SVP & Controller |
Neutral |
90.0
|
+9,800
|
53.80%
|
✗
|
- |
| Mar 3, 2025 |
Mar 4, 2025 |
Lorton Kenneth Patrick
|
COO |
Neutral |
90.0
|
+12,500
|
30.43%
|
✗
|
- |
| Mar 3, 2025 |
Mar 4, 2025 |
Tran Yvonne
|
EVP, CLO & CPO |
Neutral |
90.0
|
+12,500
|
112.26%
|
✗
|
- |
| Mar 3, 2025 |
Mar 4, 2025 |
Abel Robert Lorne
|
Officer |
Neutral |
90.0
|
+12,500
|
154.04%
|
✗
|
- |
| Feb 18, 2025 |
Feb 19, 2025 |
Tran Yvonne
|
EVP, CLO & CPO |
Sell |
10.0
|
-3,902
|
-25.95%
|
✓
|
$109.3K |
| Feb 10, 2025 |
Feb 12, 2025 |
Abel Robert Lorne
|
Officer |
Sell |
28.8
|
-1,225
|
-13.12%
|
✓
|
$31.8K |
| Feb 11, 2025 |
Feb 12, 2025 |
Lorton Kenneth Patrick
|
COO |
Sell |
45.0
|
-985
|
-2.34%
|
✓
|
$24.1K |
| Feb 11, 2025 |
Feb 12, 2025 |
Herman Jenny
|
SVP & Controller |
Sell |
41.3
|
-859
|
-4.50%
|
✓
|
$21K |
| Feb 11, 2025 |
Feb 12, 2025 |
Tran Yvonne
|
EVP, CLO & CPO |
Sell |
36.3
|
-828
|
-6.92%
|
✓
|
$20.2K |
| Oct 15, 2024 |
Oct 16, 2024 |
Dugan Margaret
|
Chief Medical Officer |
Sell |
28.8
|
-1,531
|
-10.21%
|
✓
|
$27.2K |
| Jun 18, 2024 |
Jun 20, 2024 |
Chodakewitz Jeffrey
|
Director |
Neutral |
90.0
|
+5,000
|
80.00%
|
✗
|
- |
| Jun 18, 2024 |
Jun 20, 2024 |
Kapeller-Libermann Rosana
|
Director |
Neutral |
90.0
|
+5,000
|
80.00%
|
✗
|
- |
| Jun 18, 2024 |
Jun 20, 2024 |
Lynton Michael
|
Director |
Neutral |
90.0
|
+5,000
|
80.00%
|
✗
|
- |
| Jun 18, 2024 |
Jun 20, 2024 |
OBEROI ARUN
|
Director |
Neutral |
90.0
|
+5,000
|
80.00%
|
✗
|
- |
| Jun 18, 2024 |
Jun 20, 2024 |
Sender Gary
|
Director |
Neutral |
90.0
|
+5,000
|
80.00%
|
✗
|
- |
| Jun 18, 2024 |
Jun 20, 2024 |
Thornberry Nancy
|
Director |
Neutral |
90.0
|
+5,000
|
80.00%
|
✗
|
- |
| Jun 18, 2024 |
Jun 20, 2024 |
Friesner Richard
|
Director |
Neutral |
60.0
|
+5,000
|
0.41%
|
✗
|
- |
| Jun 18, 2024 |
Jun 20, 2024 |
GINSBERG GARY L
|
Director |
Neutral |
90.0
|
+5,000
|
80.00%
|
✗
|
- |
| Mar 21, 2024 |
Mar 22, 2024 |
Abel Robert Lorne
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 21, 2024 |
Mar 22, 2024 |
Lorton Kenneth Patrick
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 6, 2024 |
Mar 7, 2024 |
Lorton Kenneth Patrick
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2024 |
Mar 5, 2024 |
Porges Geoffrey Craig
|
CFO |
Sell |
95.0
|
+5,685
|
100.00%
|
✓
|
$87.4K |
| Mar 4, 2024 |
Mar 5, 2024 |
Farid Ramy
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2024 |
Mar 5, 2024 |
Herman Jenny
|
SVP & Controller |
Neutral |
90.0
|
+7,313
|
62.18%
|
✗
|
- |
| Mar 4, 2024 |
Mar 5, 2024 |
Lorton Kenneth Patrick
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2024 |
Mar 5, 2024 |
Akinsanya Karen
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2024 |
Mar 5, 2024 |
Tran Yvonne
|
EVP, CLO & CPO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2024 |
Mar 5, 2024 |
Dugan Margaret
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2024 |
Mar 5, 2024 |
Abel Robert Lorne
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 12, 2024 |
Feb 13, 2024 |
Tran Yvonne
|
EVP, CLO & CPO |
Sell |
36.3
|
-758
|
-5.96%
|
✓
|
$21.4K |
| Feb 12, 2024 |
Feb 13, 2024 |
Abel Robert Lorne
|
Officer |
Sell |
28.8
|
-1,205
|
-11.43%
|
✓
|
$33.2K |
| Feb 12, 2024 |
Feb 13, 2024 |
Herman Jenny
|
SVP & Controller |
Sell |
36.3
|
-787
|
-6.27%
|
✓
|
$22.3K |
| Feb 12, 2024 |
Feb 13, 2024 |
Lorton Kenneth Patrick
|
COO |
Sell |
45.0
|
-901
|
-2.41%
|
✓
|
$25.5K |
| Sep 15, 2023 |
Sep 18, 2023 |
Herman Jenny
|
SVP & Controller |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 9, 2023 |
Aug 10, 2023 |
Dugan Margaret
|
Chief Medical Officer |
Neutral |
90.0
|
+15,000
|
100.00%
|
✗
|
- |
| Aug 9, 2023 |
Aug 10, 2023 |
Lorton Kenneth Patrick
|
EVP & Chief Technology Officer |
Sell |
12.5
|
-10,000
|
-21.10%
|
✓
|
$400.6K |
|
Aug 3, 2023 |
Dugan Margaret
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 30, 2023 |
Jul 3, 2023 |
Tran Yvonne
|
EVP, CLO & CPO |
Sell |
7.5
|
-12,040
|
-48.62%
|
✓
|
$602K |
| Jun 15, 2023 |
Jun 16, 2023 |
Thornberry Nancy
|
Director |
Neutral |
90.0
|
+6,250
|
100.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
Chodakewitz Jeffrey
|
Director |
Neutral |
90.0
|
+6,250
|
100.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
Kapeller-Libermann Rosana
|
Director |
Neutral |
90.0
|
+6,250
|
100.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
GINSBERG GARY L
|
Director |
Neutral |
90.0
|
+6,250
|
100.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
Friesner Richard
|
Director |
Neutral |
67.5
|
+6,250
|
0.51%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
Sender Gary
|
Director |
Neutral |
90.0
|
+6,250
|
100.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
OBEROI ARUN
|
Director |
Neutral |
90.0
|
+6,250
|
100.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
Lynton Michael
|
Director |
Neutral |
90.0
|
+6,250
|
100.00%
|
✗
|
- |
| May 22, 2023 |
May 24, 2023 |
Tran Yvonne
|
EVP, CLO & CPO |
Sell |
7.5
|
-22,960
|
-47.44%
|
✓
|
$844.1K |
| May 23, 2023 |
May 24, 2023 |
Lorton Kenneth Patrick
|
EVP & Chief Technology Officer |
Sell |
17.5
|
-10,000
|
-17.43%
|
✓
|
$400.6K |
| May 22, 2023 |
May 23, 2023 |
Thornberry Nancy
|
Director |
Sell |
7.5
|
-14,850
|
-100.00%
|
✓
|
$519.8K |
| Feb 9, 2023 |
Feb 10, 2023 |
Tran Yvonne
|
EVP & Chief Legal Officer |
Neutral |
90.0
|
+7,590
|
147.92%
|
✗
|
- |
| Feb 9, 2023 |
Feb 10, 2023 |
Porges Geoffrey Craig
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 9, 2023 |
Feb 10, 2023 |
Lorton Kenneth Patrick
|
EVP & Chief Technology Officer |
Neutral |
90.0
|
+8,170
|
16.60%
|
✗
|
- |
| Feb 9, 2023 |
Feb 10, 2023 |
Herman Jenny
|
SVP & Controller |
Neutral |
90.0
|
+8,000
|
266666.67%
|
✗
|
- |
| Feb 9, 2023 |
Feb 10, 2023 |
Farid Ramy
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 9, 2023 |
Feb 10, 2023 |
Akinsanya Karen
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 9, 2023 |
Feb 10, 2023 |
Abel Robert Lorne
|
Officer |
Neutral |
90.0
|
+10,545
|
100.00%
|
✗
|
- |
| Feb 2, 2023 |
Feb 3, 2023 |
Tran Yvonne
|
EVP & Chief Legal Officer |
Sell |
7.5
|
-25,000
|
-82.97%
|
✓
|
$681.4K |
| Jan 4, 2023 |
Jan 5, 2023 |
Farid Ramy
|
CEO |
Sell |
5.0
|
-66,886
|
-26.61%
|
✓
|
$1.2M |